The Digital Therapeutics (DTx) Market size was estimated at USD 6.30 billion in 2023 and is expected to reach USD 44.13 billion by 2031 at a CAGR of 31.02% during the forecast period of 2024-2031.
The cost-effectiveness of digital health technology for providers and patients, as well as increased smartphone prevalence in both developed and developing nations, are driving market expansion. Furthermore, the rising prevalence of chronic illnesses leads to market expansion. According to the CDC's National Centre for Chronic Condition Prevention and Health Promotion, one in every ten American adults has a chronic condition, and one in every ten individuals has three or more chronic diseases. Digital therapeutics (DTx) refers to software and technologies that digitally preserve evidence-based therapeutic treatments for illness prevention and management. The software and gadgets help in the treatment of a variety of mental health, diabetic, respiratory, and cardiovascular issues.
Get more information on Digital Therapeutics Market - Request Free Sample Report
DRIVERS
Controlling healthcare expenses is essential.
One of the key market drivers is the desire to control healthcare expenditures. Digital treatments are low-cost, non-invasive alternatives to traditional therapy. They give patients access to personalised, low-cost care. Digital medicines are also being utilised to lower healthcare costs and improve care delivery efficiency. With healthcare costs growing, digital therapies provide a cost-effective way to provide treatment. Digital treatments can also help enhance patient outcomes and decrease hospital readmissions. This has the potential to significantly reduce healthcare expenses.
RESTRAIN
Concerns about patient data security.
OPPORTUNITY
Therapeutic uses that have yet to be discovered.
As an alternative to traditional therapies, digital therapeutics are gaining popularity. The market is likely to expand rapidly in the coming years, owing to the growing acceptability of digital therapies among healthcare professionals and patients. Digital therapies have several unknown therapeutic potentials. Digital treatments, for example, can be used to treat disorders including autism, Alzheimer's disease, depression, anxiety, and chronic pain. Because digital medicines may adjust treatments to an individual's particular needs, they also provide prospects for personalised healthcare. Furthermore, digital therapies have the potential to lower healthcare costs by replacing or supplementing more expensive treatments such as medicines or surgery.
CHALLENGES
Uncertain payment models.
The violence may result in limited market access and acceptance for Digital Therapeutics firms, particularly in places immediately affected by the fighting. In these locations, healthcare systems may prioritise emergency needs while allocating limited resources to other healthcare goals. This has the potential to limit the adoption of Digital therapeutic solutions and hinder market growth in such sectors. Talent and knowledge are being displaced. During times of violence, people and their experiences, especially healthcare professionals and technological specialists, may be displaced. This has the potential to have an influence on the development, implementation, and uptake of Digital therapeutic solutions in impacted regions. Brain drain and talent movement might lead to a skilled workforce shortage, impeding the growth and expansion of the Digital Therapeutics industry.
Funding and investment issues The Russia-Ukraine conflict, as well as the associated economic and geopolitical uncertainty, may have an influence on funding and investment prospects for Digital Therapeutics firms. Venture capital businesses and investors may become more cautious or shift their investments to less volatile markets. As a result, financing availability may be restricted, slowing the rate of innovation and market development.
By Sales Channel
B2C
Patients
Caregivers
B2B
Providers
Payers
Employers
Pharmaceutical Companies
Other Buyers
By Application
Preventive Applications
Prediabetes
Obesity
Nutrition
Lifestyle Management
Other Preventive Applications
Treatment/Care-related Applications
Diabetes
CNS Disorders
Mental Health Disorder
Other CNS Disorders
Chronic Respiratory Disorders
Musculoskeletal Disorders
Cardiovascular Diseases
Smoking Cessation
Medication Adherence
Gastrointestinal Disorders
Substance Use & Addiction Management
Rehabilitation & Patient Care
Other Treatment/Care-related Applications
Need any customization research on Digital Therapeutics Market - Enquiry Now
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
REGIONAL ANALYSES
North America led the market in 2022, accounting for 40.8% of total revenue. The region's total market is predicted to develop considerably over the forecast period as a result of favourable reimbursement scenarios focusing on enhanced tracking and diagnostics, as well as improved quality of life through higher usage of digital health goods. Furthermore, prominent players in this region's strategic activities, such as new product launches and mergers and acquisitions, are projected to result in profitable development.
Due to strong demand for IT services and rising government expenditure on healthcare, Asia Pacific is expected to develop rapidly, with the fastest CAGR of 28.9% during the projected period. Furthermore, as they enable effective administration of hospitals' clinical, financial, and administrative elements, demand for healthcare IT systems is expanding. The underlying elements allowing a quick expansion in Asia Pacific's digital therapeutics industry include increased smartphone usage, increased demand for effective healthcare, and enhanced internet connectivity.
The major key players are OMADA HEALTH, INC, Welldoc, Inc, 2Morrow, Inc, Livongo Health, Inc. (Teladoc Health, Inc.), Propeller Health (ResMed), Fitbit LLC, CANARY HEALTH, Noom, Inc, Pear Therapeutics, Inc, Akili Interactive Labs, Inc.
Lupin: In January 2023, Lupin, a wholly owned subsidiary of Lupin Limited, launched its medicines solution, LYFE. LYFE is India's only evidence-based comprehensive heart care programme that drastically decreases the chance of a heart attack while also improving cardiac patients' vitals and quality of life.
Fitbit Health Solutions: In February 2022, Fitbit Health Solutions announced a collaboration with Pretaa to enhance outcomes for Americans and their families affected by drug misuse by incorporating health and exercise data into Pretaa's substance abuse rehabilitation app.
| Report Attributes | Details |
| Market Size in 2023 | US$ 6.30 Bn |
| Market Size by 2031 | US$ 44.13 Bn |
| CAGR | CAGR of 31.02% From 2024 to 2031 |
| Base Year | 2023 |
| Forecast Period | 2024-2031 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Sales Channel (B2C, Patients, Caregivers, B28) • By Application (Preventive Applications, Treatment/Care-related Applications) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]). Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Company Profiles | OMADA HEALTH, INC, Welldoc, Inc, 2Morrow, Inc, Livongo Health, Inc. (Teladoc Health, Inc.), Propeller Health (ResMed), Fitbit LLC, CANARY HEALTH, Noom, Inc, Pear Therapeutics, Inc, Akili Interactive Labs, Inc. |
| Key Drivers | • Controlling healthcare expenses is essential. |
| Market Restraints | • Concerns about patient data security. |
Ans: Digital Therapeutics Market is anticipated to expand by 31.8% from 2023 to 2030.
Ans: USD 40.06 billion is expected to grow by 2030.
Ans: The top companies in the market for Digital Therapeutics are OMADA HEALTH, INC, Welldoc, Inc, 2Morrow, Inc, Livongo Health, Inc. (Teladoc Health, Inc.), Propeller Health (ResMed).
Ans: Digital Therapeutics Market size was valued at USD 5.79 billion in 2022.
Ans: The diabetes category led the worldwide digital therapeutics market in 2022, accounting for more than 29.0% of total revenue.
TABLE OF CONTENTS
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 Impact of the Russia-Ukraine War
4.2 Impact of Ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Digital Therapeutics Market Segmentation, By Sales Channel
8.1 B2C
8.2 Patients
8.3 Caregivers
8.4 B28
8.5 Providers
8.6 Payers
8.7 Employers
8.8 Pharmaceutical Companies
8.9 Other Buyers
9. Digital Therapeutics Market Segmentation, By Application
9.1 Preventive Applications
9.2 Treatment/Care-related Applications
10. Regional Analysis
10.1 Introduction
10.2 North America
10.2.1 North America Digital Therapeutics Market, by Country
10.2.2North America Digital Therapeutics Market, By Sales Channel
10.2.3 North America Digital Therapeutics Market, By Application
10.2.4 USA
10.2.4.1 USA Digital Therapeutics Market, By Sales Channel
10.2.4.2 USA Digital Therapeutics Market, By Application
10.2.5 Canada
10.2.5.1 Canada Digital Therapeutics Market, By Sales Channel
10.2.5.2 Canada Digital Therapeutics Market, By Application
10.2.6 Mexico
10.2.6.1 Mexico Digital Therapeutics Market By Sales Channel
10.2.6.2 Mexico Digital Therapeutics Market By Application
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Eastern Europe Digital Therapeutics Market by Country
10.3.1.2 Eastern Europe Digital Therapeutics Market By Sales Channel
10.3.1.3 Eastern Europe Digital Therapeutics Market By Application
10.3.1.4 Poland
10.3.1.4.1 Poland Digital Therapeutics Market By Sales Channel
10.3.1.4.2 Poland Digital Therapeutics By Application
10.3.1.5 Romania
10.3.1.5.1 Romania Digital Therapeutics Market By Sales Channel
10.3.1.5.2 Romania Digital Therapeutics Market By Application
10.3.1.6 Hungary
10.3.1.6.1 Hungary Digital Therapeutics Market By Sales Channel
10.3.1.6.2 Hungary Digital Therapeutics Market By Application
10.3.1.7 Turkey
10.3.1.7.1 Turkey Digital Therapeutics Market By Sales Channel
10.3.1.7.2 Turkey Digital Therapeutics Market By Application
10.3.1.8 Rest of Eastern Europe
10.3.1.8.1 Rest of Eastern Europe Digital Therapeutics Market By Sales Channel
10.3.1.8.2 Rest of Eastern Europe Digital Therapeutics Market By Application
10.3.2 Western Europe
10.3.2.1 Western Europe Digital Therapeutics Market by Country
10.3.2.2 Western Europe Digital Therapeutics Market By Sales Channel
10.3.2.3 Western Europe Digital Therapeutics Market By Application
10.3.2.4 Germany
10.3.2.4.1 Germany Digital Therapeutics Market By Sales Channel
10.3.2.4.2 Germany Digital Therapeutics Market By Application
10.3.2.5 France
10.3.2.5.1 France Digital Therapeutics Market By Sales Channel
10.3.2.5.2 France Digital Therapeutics Market By Application
10.3.2.6 UK
10.3.2.6.1 UK Digital Therapeutics Market By Sales Channel
10.3.2.6.2 UK Digital Therapeutics Market By Application
10.3.2.7 Italy
10.3.2.7.1 Italy Digital Therapeutics Market By Sales Channel
10.3.2.7.2 Italy Digital Therapeutics Market By Application
10.3.2.8 Spain
10.3.2.8.1 Spain Digital Therapeutics Market By Sales Channel
10.3.2.8.2 Spain Digital Therapeutics Market By Application
10.3.2.9 Netherlands
10.3.2.9.1 Netherlands Digital Therapeutics Market By Sales Channel
10.3.2.9.2 Netherlands Digital Therapeutics Market By Application
10.3.2.10 Switzerland
10.3.2.10.1 Switzerland Digital Therapeutics Market By Sales Channel
10.3.2.10.2 Switzerland Digital Therapeutics Market By Application
10.3.2.11 Austria
10.3.2.11.1 Austria Digital Therapeutics Market By Sales Channel
10.3.2.11.2 Austria Digital Therapeutics Market By Application
10.3.2.12 Rest of Western Europe
10.3.2.12.1 Rest of Western Europe Digital Therapeutics Market By Sales Channel
10.3.2.12.2 Rest of Western Europe Digital Therapeutics Market By Application
10.4 Asia-Pacific
10.4.1 Asia Pacific Digital Therapeutics Market by Country
10.4.2 Asia Pacific Digital Therapeutics Market By Sales Channel
10.4.3 Asia Pacific Digital Therapeutics Market By Application By Sales Channel
10.4.4 China
10.4.4.1 China Digital Therapeutics Market By Sales Channel
10.4.4.2 China Digital Therapeutics Market By Application
10.4.5 India
10.4.5.1 India Digital Therapeutics Market By Sales Channel
10.4.5.2 India Digital Therapeutics Market By Application
10.4.6 Japan
10.4.6.1 Japan Digital Therapeutics Market By Sales Channel
10.4.6.2 Japan Digital Therapeutics Market By Application
10.4.7 South Korea
10.4.7.1 South Korea Digital Therapeutics Market By Sales Channel
10.4.7.2 South Korea Digital Therapeutics Market By Application
10.4.8 Vietnam
10.4.8.1 Vietnam Digital Therapeutics Market By Sales Channel
10.4.8.2 Vietnam Digital Therapeutics Market By Application
10.4.9 Singapore
10.4.9.1 Singapore Digital Therapeutics Market By Sales Channel
10.4.9.2 Singapore Digital Therapeutics Market By Application
10.4.10 Australia
10.4.10.1 Australia Digital Therapeutics Market By Sales Channel
10.4.10.2 Australia Digital Therapeutics Market By Application
10.4.11 Rest of Asia-Pacific
10.4.11.1 Rest of Asia-Pacific Digital Therapeutics Market By Sales Channel
10.4.11.2 Rest of Asia-Pacific Digital Therapeutics Market By Application
10.5 Middle East & Africa
10.5.1 Middle East
10.5.1.1 Middle East Digital Therapeutics Market by Country
10.5.1.2 Middle East Digital Therapeutics Market By Sales Channel
10.5.1.3 Middle East Digital Therapeutics Market By Application
10.5.1.4 UAE
10.5.1.4.1 UAE Digital Therapeutics Market By Sales Channel
10.5.1.4.2 UAE Digital Therapeutics Market By Application
10.5.1.5 Egypt
10.5.1.5.1 Egypt Digital Therapeutics Market By Sales Channel
10.5.1.5.2 Egypt Digital Therapeutics Market By Application
10.5.1.6 Saudi Arabia
10.5.1.6.1 Saudi Arabia Digital Therapeutics Market By Sales Channel
10.5.1.6.2 Saudi Arabia Digital Therapeutics Market By Application
10.5.1.7 Qatar
10.5.1.7.1 Qatar Digital Therapeutics Market By Sales Channel
10.5.1.7.2 Qatar Digital Therapeutics Market By Application
10.5.1.8 Rest of Middle East
10.5.1.8.1 Rest of Middle East Digital Therapeutics Market By Sales Channel
10.5.1.8.2 Rest of Middle East Digital Therapeutics Market By Application
10.5.2 Africa
10.5.2.1 Africa Digital Therapeutics Market by Country
10.5.2.2 Africa Digital Therapeutics Market By Sales Channel
10.5.2.3 Africa Digital Therapeutics Market By Application
10.5.2.4 Nigeria
10.5.2.4.1 Nigeria Digital Therapeutics Market By Sales Channel
10.5.2.4.2 Nigeria Digital Therapeutics Market By Application
10.5.2.5 South Africa
10.5.2.5.1 South Africa Digital Therapeutics Market By Sales Channel
10.5.2.5.2 South Africa Digital Therapeutics Market By Application
10.5.2.6 Rest of Africa
10.5.2.6.1 Rest of Africa Digital Therapeutics Market By Sales Channel
10.5.2.6.2 Rest of Africa Digital Therapeutics Market By Application
10.6 Latin America
10.6.1 Latin America Digital Therapeutics Market by Country
10.6.2 Latin America Digital Therapeutics Market By Sales Channel
10.6.3 Latin America Digital Therapeutics Market By Application
10.6.4 Brazil
10.6.4.1 Brazil Digital Therapeutics Market By Sales Channel
10.6.4.2 Brazil Digital Therapeutics Market By Application
10.6.5 Argentina
10.6.5.1 Argentina Digital Therapeutics Market By Sales Channel
10.6.5.2 Argentina Digital Therapeutics Market By Application
10.6.6 Colombia
10.6.6.1 Colombia Digital Therapeutics Market By Sales Channel
10.6.6.2 Colombia Digital Therapeutics Market By Application
10.6.7 Rest of Latin America
10.6.7.1 Rest of Latin America Digital Therapeutics Market By Sales Channel
10.6.7.2 Rest of Latin America Digital Therapeutics Market By Application
11 Company Profile
11.1 OMADA HEALTH, INC.
11.1.1 Company Overview
11.1.2 Financials
11.1.3 Product/Services Offered
11.1.4 SWOT Analysis
11.1.5 The SNS View
11.2 Welldoc, Inc.
11.2.1 Company Overview
11.2.2 Financials
11.2.3 Product/Services Offered
11.2.4 SWOT Analysis
11.2.5 The SNS View
11.3 2 Morrow, Inc
11.3.1 Company Overview
11.3.2 Financials
11.3.3 Product/Services Offered
11.3.4 SWOT Analysis
11.3.5 The SNS View
11.4 Livongo Health, Inc.
11.4 Company Overview
11.4.2 Financials
11.4.3 Product/Services Offered
11.4.4 SWOT Analysis
11.4.5 The SNS View
11.5 Propeller Health (ResMed)
11.5.1 Company Overview
11.5.2 Financials
11.5.3 Product/Services Offered
11.5.4 SWOT Analysis
11.5.5 The SNS View
11.6 Fitbit LLC
11.6.1 Company Overview
11.6.2 Financials
11.6.3 Product/Services Offered
11.6.4 SWOT Analysis
11.6.5 The SNS View
11.7 CANARY HEALTH
11.7.1 Company Overview
11.7.2 Financials
11.7.3 Product/Services Offered
11.7.4 SWOT Analysis
11.7.5 The SNS View
11.8 Noom, Inc.
11.8.1 Company Overview
11.8.2 Financials
11.8.3 Product/Services Offered
11.8.4 SWOT Analysis
11.8.5 The SNS View
11.9 Pear Therapeutics, Inc.
11.9.1 Company Overview
11.9.2 Financials
11.9.3 Product/ Services Offered
11.9.4 SWOT Analysis
11.9.5 The SNS View
11.10 Akili Interactive Labs, Inc.
11.10.1 Company Overview
11.10.2 Financials
11.10.3 Product/Services Offered
11.10.4 SWOT Analysis
11.10.5 The SNS View
12. Competitive Landscape
12.1 Competitive Bench marking
12.2 Market Share Analysis
12.3 Recent Developments
12.3.1 Industry News
12.3.2 Company News
12.3.3 Mergers & Acquisitions
13. USE Cases and Best Practices
14. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Wearable Medical Devices Market is expected to reach USD 210.66 billion by 2031, and its Size was valued at USD 33.8 billion in 2023, it grows at a CAGR of 25.7% over the forecast period 2024-2031.
The Oncology Information System Market Size was valued at USD 3.36 billion in 2023, and is expected to reach USD 6.13 billion by 2031, and grow at a CAGR of 7.8% over the forecast period 2024-2031.
The Biopharmaceutical market size was valued USD 333 billion in 2022 and is expected to reach USD 854.6 billion by 2030 and grow at a CAGR of 12.5% over the forecast period of 2023-2030.
The Metagenomics Market size was estimated USD 1.8 billion in 2022 and is expected to reach USD 5.9 billion by 2030 at a CAGR of 16.2% during the forecast period of 2023-2030.
In 2022 the global market for Demineralized Bone Matrix (DBM) is estimated to reach USD 648,23 million with a forecast compound annual growth rate of 4.5 % until 2030 and it will go up to USD 920,84 million by 2030.
The Medical Decision Support Systems for Sepsis Market Size was valued at USD 36.17 million in 2022, and is expected to reach USD 211.51 million by 2030, and grow at a CAGR of 24.7% over the forecast period 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
